Quarterly report · Q3
2934.TEDINET S100QLF7
Period2022-06-01 → 2023-02-28
Filed2023-04-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 35
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥12.7bn | 2022-06-01 → 2023-02-28 | Cons. | Net sales |
| Revenue | ¥11.9bn | 2021-06-01 → 2022-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥7.4bn | 2021-06-01 → 2022-02-28 | Cons. | Net sales |
| Operating income | −¥690m | 2022-06-01 → 2023-02-28 | Cons. | Operating income |
| Operating income | ¥575m | 2021-06-01 → 2022-02-28 | Cons. | Operating income |
| Ordinary income | −¥709m | 2022-06-01 → 2023-02-28 | Cons. | Ordinary income |
| Ordinary income | ¥712m | 2021-06-01 → 2022-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥550m | 2021-06-01 → 2022-02-28 | Cons. | Ordinary income |
| Profit before tax | −¥710m | 2022-06-01 → 2023-02-28 | Cons. | Income before income taxes |
| Profit before tax | ¥550m | 2021-06-01 → 2022-02-28 | Cons. | Income before income taxes |
| Net income (owners) | −¥604m | 2022-06-01 → 2023-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥401m | 2021-06-01 → 2022-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥353m | 2021-06-01 → 2022-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥559m | 2022-06-01 → 2023-02-28 | Cons. | Profit loss |
| Net income | ¥353m | 2021-06-01 → 2022-02-28 | Cons. | Profit loss |
| Total assets | ¥7.8bn | at 2023-02-28 | Cons. | Assets |
| Total assets | ¥6.1bn | at 2022-05-31 | Cons. | Assets |
| Total assets | ¥5.5bn | at 2022-02-28 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥3.8bn | at 2023-02-28 | Cons. | Liabilities |
| Total liabilities | ¥1.9bn | at 2022-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥4.0bn | at 2023-02-28 | Cons. | Net assets |
| Net assets / equity | ¥4.2bn | at 2022-05-31 | Cons. | Net assets |
| Net assets / equity | ¥4.1bn | at 2022-02-28 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.4bn | at 2023-02-28 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.0bn | at 2022-05-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥-131.07 | 2022-06-01 → 2023-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-54.37 | 2022-12-01 → 2023-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥90.64 | 2021-06-01 → 2022-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥80.6 | 2021-06-01 → 2022-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.28 | 2021-12-01 → 2022-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥86.68 | 2021-06-01 → 2022-05-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥76.33 | 2021-06-01 → 2022-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 48.3% | at 2023-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.8% | at 2022-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.5% | at 2022-02-28 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 35
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-06-01 → 2023-02-28 | −¥139m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-06-01 → 2023-02-28 | −¥139m |
| Reconciling Itemsreconciling | segment profit | 2022-06-01 → 2023-02-28 | −¥385m |
| jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥4.0bn |
| jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥3.9bn |
| jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segment | revenue intersegment | 2022-06-01 → 2023-02-28 | ¥139m |
| jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segment | segment profit | 2022-06-01 → 2023-02-28 | ¥19m |
| jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥3.0bn |
| jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥3.0bn |
| jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segment | segment profit | 2022-06-01 → 2023-02-28 | ¥252m |
| jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥5.8bn |
| jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥5.8bn |
| jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segment | revenue intersegment | 2022-06-01 → 2023-02-28 | ¥458,000 |
| jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segment | segment profit | 2022-06-01 → 2023-02-28 | −¥576m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-06-01 → 2023-02-28 | ¥12.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-06-01 → 2023-02-28 | ¥12.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-06-01 → 2023-02-28 | ¥139m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-06-01 → 2023-02-28 | −¥305m |
| Reconciling Itemsreconciling | revenue | 2021-06-01 → 2022-02-28 | −¥27m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-06-01 → 2022-02-28 | −¥27m |
| Reconciling Itemsreconciling | segment profit | 2021-06-01 → 2022-02-28 | −¥270m |
| jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segment | revenue | 2021-06-01 → 2022-02-28 | ¥2.0bn |
| jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segment | revenue external | 2021-06-01 → 2022-02-28 | ¥2.0bn |
| jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segment | revenue intersegment | 2021-06-01 → 2022-02-28 | ¥27m |
| jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segment | segment profit | 2021-06-01 → 2022-02-28 | ¥45m |
| jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segment | revenue | 2021-06-01 → 2022-02-28 | ¥2.6bn |
| jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segment | revenue external | 2021-06-01 → 2022-02-28 | ¥2.6bn |
| jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segment | segment profit | 2021-06-01 → 2022-02-28 | ¥666m |
| jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segment | revenue | 2021-06-01 → 2022-02-28 | ¥2.9bn |
| jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segment | revenue external | 2021-06-01 → 2022-02-28 | ¥2.9bn |
| jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segment | segment profit | 2021-06-01 → 2022-02-28 | ¥134m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-06-01 → 2022-02-28 | ¥7.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-06-01 → 2022-02-28 | ¥7.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-06-01 → 2022-02-28 | ¥27m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-06-01 → 2022-02-28 | ¥845m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 342
| Item | Context | Value | Unit |
|---|---|---|---|
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 200000 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0412 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 200000 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | - | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 200000 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0412 | |
| Cash and deposits | Prior1YearInstant | 2956408000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 2400691000 | JPY |
| Accounts receivable trade | Prior1YearInstant | 1334228000 | JPY |
| Accounts receivable trade | CurrentQuarterInstant | 1467019000 | JPY |
| Merchandise and finished goods | Prior1YearInstant | 407803000 | JPY |
| Merchandise and finished goods | CurrentQuarterInstant | 908284000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 39218000 | JPY |
| Raw materials and supplies | CurrentQuarterInstant | 37420000 | JPY |
| Work in process | Prior1YearInstant | 21104000 | JPY |
| Work in process | CurrentQuarterInstant | 26974000 | JPY |
| Prepaid expenses | Prior1YearInstant | 126832000 | JPY |
| Prepaid expenses | CurrentQuarterInstant | 171643000 | JPY |
| Other ca | Prior1YearInstant | 39587000 | JPY |
| Other ca | CurrentQuarterInstant | 245338000 | JPY |
| Allowance for doubtful accounts ca | Prior1YearInstant | -3788000 | JPY |
| Allowance for doubtful accounts ca | CurrentQuarterInstant | -3911000 | JPY |
| Current assets | Prior1YearInstant | 4921394000 | JPY |
| Current assets | CurrentQuarterInstant | 5253461000 | JPY |
| Property plant and equipment | Prior1YearInstant | 47995000 | JPY |
| Property plant and equipment | CurrentQuarterInstant | 139098000 | JPY |
| Goodwill | Prior1YearInstant | 815912000 | JPY |
| Goodwill | CurrentQuarterInstant | 1578440000 | JPY |
| Other ia | Prior1YearInstant | 113070000 | JPY |
| Other ia | CurrentQuarterInstant | 216167000 | JPY |
| Intangible assets | Prior1YearInstant | 928982000 | JPY |
| Intangible assets | CurrentQuarterInstant | 1794608000 | JPY |
| Investments and other assets | Prior1YearInstant | 200922000 | JPY |
| Investments and other assets | CurrentQuarterInstant | 598882000 | JPY |
| Noncurrent assets | Prior1YearInstant | 1177900000 | JPY |
| Noncurrent assets | CurrentQuarterInstant | 2532589000 | JPY |
| Assets | Prior1YearInstant | 6099295000 | JPY |
| Assets | CurrentQuarterInstant | 7786050000 | JPY |
| Accounts payable trade | Prior1YearInstant | 524591000 | JPY |
| Accounts payable trade | CurrentQuarterInstant | 737365000 | JPY |
| Short term loans payable | Prior1YearInstant | - | JPY |
| Short term loans payable | CurrentQuarterInstant | 228334000 | JPY |
| Current portion of bonds | Prior1YearInstant | - | JPY |
| Current portion of bonds | CurrentQuarterInstant | 66000000 | JPY |
| Current portion of long term loans payable | Prior1YearInstant | 84195000 | JPY |
| Current portion of long term loans payable | CurrentQuarterInstant | 395994000 | JPY |
| Accounts payable other | Prior1YearInstant | 357143000 | JPY |
| Accounts payable other | CurrentQuarterInstant | 687623000 | JPY |
| Accrued expenses | Prior1YearInstant | 114384000 | JPY |
| Accrued expenses | CurrentQuarterInstant | 102403000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |